AbbVie tokenized stock (xStock)

Built on blockchain technology, AbbVie tokenized stock (xStock) is a tracker certificate issued as Solana SPL and ERC-20 tokens, designed to provide eligible cryptocurrency market participants with regulatory-compliant access to the stock price of AbbVie Inc. This innovative solution maintains the benefits of blockchain technology while giving investors exposure to the global biopharmaceutical company's stock.

The key technical features of ABBVX include its issuance as both Solana SPL and ERC-20 tokens, allowing for compatibility with various blockchain ecosystems. The tracker certificate charges no management fee at present, although a fee of up to 0.25% per year may be introduced in the future. Additionally, a fee of up to 0.50% of the investment's value is applicable when entering and exiting the investment.

ABBVX offers several use cases and utility for investors. As a tokenized representation of AbbVie Inc.'s stock, it allows for fractional ownership and increased liquidity. The token can be used in various DeFi applications, such as lending and borrowing, while also providing exposure to the biopharmaceutical company's diversified pipeline and established products like Humira.

The issuer of the underlying is AbbVie Inc., a global biopharmaceutical company focused on developing and delivering innovative therapies in areas such as immunology, oncology, neuroscience, and eye care. The security agent for ABBVX is Security Agent Services AG. Notable service providers include Alpaca Securities LLC, InCore Bank AG, and Maerki Baumann & Co. AG.

ABBVX has been listed on various platforms, including CoinGecko, where it can be viewed alongside other tokenized financial assets. The product details are available for download from the Backed Assets website, along with key information documents in multiple languages.